occluded. All secondary spontaneous thromboses (27.6% of cases), occurred during the first year pos-embolisation. In six patients with subtotal or partial occlusion no change was seen for three consecutive years of FU; none showed later change at 5-year angiography. Below 80% occlusion our series does not provide enough information but we consider the situation instable.
Introduction
Surgical clipping has long been the accepted treatment worldwide, for intracranial saccular arterial aneurysms (AA) 1 . It is now 12 years since the first clinical use of a Guglielmi Detachable Coil (GDC) (Target Therapeutics, Boston Scientific, Fremont CA) in a human intracranial AA 2, 3 . The technique has evolved from a procedure under evaluation, via an accepted alternative treatment of high surgical risk AA 4 to become today, the primary form of
Summary
The purpose of the paper is the follow-up of embolised intradural saccular Arterial Aneurysms (AA), excluding giant, dissecting, inflammatory, fusiform or AA associated to BVAM.
Since its introduction in 1991, the Guglielmi Detachable Coil has offered protection against aneurysmal rebleeding in the critical few days and months after SAH regardless of the grade. A number of questions remain: is complete angiographic obliteration necessary at first embolisation? What duration of clinical / angiographic follow-up (FU) is required to ensure the risk of haemorrhage has been eliminated? What is the long-term protection against rebleeding?
One hundred and two patients with 160 intradural saccular AA embolised before april 1997 were selected for this study. They had at least 5-yrs clinical FU, of which 22 patients had a mid-term (3 years) and 45 patients had a 5year or more angiographic FU (mean 67,7 months per patient).
Twenty-eight embolised AAs with 100% occlusion at 1 year, remained unchanged on the 5year angiograms. A further 14 patients with complete occlusion at 1 year showed persisting complete occlusion on angiogram at 3-years FU, which in our series means that complete occlusion after the first year post-embolisation implies that the aneurysm will remain completely 5-year Angiographic and Clinical Follow-up of Coil-embolised Intradural Saccular Aneurysms A Single Center Experience LL. BATISTA, J. MAHADEVAN, M. SACHET, H. ALVAREZ, G. RODESCH, P. LASJAUNIAS 350 treatment in many centers. GDCs are now widely used in ruptured and unruptured intracranial saccular AAs in the anterior 5 and posterior circulation 6 . In august 2002 it was estimated that over 100.000 patients had been treated with GDCs worldwide 7 .
The goal in treating ruptured aneurysm is to prevent rebleeding. Without treatment recurrent haemorrhage occurs in more than 30% during the first few months following subarachnoid haemorrhage (SAH) 8 . Coiling ruptured AAs with GDCs has proved effective in avoiding early rebleeding, but the lack of long-term angiographic studies following endovascular treatment leaves many questions regarding the late stability of coiled aneurysms. In most published series, the majority of patients have a short period of follow-up.
Our aim was to provide such data on the stability of endosaccular packing of AAs and its long-term efficacy in protecting against bleeding. Long-term clinical and angiographic follow-up data for ruptured and unruptured aneurysms were analysed. Our series comprises patients embolised between 1993 and 1997 and followed clinically; in addition, some of them had at least 5-year control angiography.
To our knowledge this study is unique in supplying detailed angiographic data on a significant number of patients five years after embolisation.
Material and Methods

Clinical Data
We began treating patients with GDC in 1993 participating to the French evaluation of GDC. During this first year only non-surgical aneurysms were treated 9 . Since then, when coiling has been considered feasible, all intradural AAs have undergone endovascular treatment 10 .
Region
Location No % A prospective database has been maintained since 1993 recording initial clinical and anatomic findings, treatment clinical and angiographic outcomes.
Technical Aspects
The protocol we use is the same since 1993 9 . All procedures were performed by femoral approach with 6 F guiding catheters. Procedures are performed under heparinisation (a bolus of intravenous heparin (50 UI/kg) is followed by infusion of 500-1500 UI/h). For ruptured AAs heparin is started after detachment of the first coil within the aneurysm sac. All catheters are continouously flushed with non-heparinised saline. Ruptured AA are treated as soon as possible, the majority at the same time than diagnostic angiography, as a continuation of the same procedure, or at the latest within three days after onset of SAH. Our criteria for embolisation of ruptured AAs includes suitable anatomy 14 , appropriate sac/neck and neck/parent vessel diameter ratio 9 , a clear "working projection" allowing continuous visualisation of neck of the AA or dangerous branches. 3Dangiography (GE Advantix LCN+, SUN workstation) allows a precise analysis in most cases. Surgical clipping is performed if emergency evacuaton of ipsilateral haematoma is required, where aneurysm morphology is considered unsuitable for embolisation, when the endovascular procedure fails or if multiple AA are in the same surgical field and one of them is not coilable. The aneurysm is approached under fluoroscopy and road-mapping with a Tracker microcatheter (Boston Therapeutics, Fremont, CA). All ruptured AA and small-unruptured AAs are treated with GDC 10. GDC 18 are used in cases of unruptured AA > 8 mm in diameter. Complete exclusion of the AA it self is attempted in every case. We seldom use the "remodelling technique" 15 ; we do not use it in acute phase of ruptured AA. We avoid "overpacking" ruptured AA as it includes packing of the false sac. Such technical choice is associated with intra-operative or early re rupture of AA and secondary migration of coils into the false sac. Heparinization is maintained for 24 h with the activated clotting time at twice the baseline. The introducer sheath is left in place during this time period and removed after discontinuation of heparinization. Intensive care support always includes calcium- channel blockers, control of mean arterial pressure, and steroids when increased mass effect from the coils is anticipated (e.g., basilar tip AA lying on mesencephalon). A plain X-ray film of the skull is obtained at 24 h to document the position and stability of the coils.
Follow-up -Scores
In all patients follow-up outcome from ruptured AA is assessed with Karnovsky Score 16 and Glasgow Outcome Score (GOS). GOS 1 indicates good recovery without neurological deficit and GOS 5 indicates death 17 In all cases follow-up DSA is expected at three months and 1 year after treatment, with further angiography proposed at 3 and 5 years. Intermediate control angiograms at 6 months are performed in cases of partial occlusion of the AA, recanalisation or regrowth of the lesion was demonstrated. If needed, the AA is embolised again during one of these sessions. 
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In such situation, the follow-up protocol is restarted. We assessed the rate of occlusion as follows: complete angiographic exclusion of the sac was considered a 100% occclusion; a persistent neck on one projection was equivalent to 90-99%, and 80-89% when demonstrated on two projections. Partial opacification of the aneurismal sac itself was considered a less than 80% occlusion rate.
Material
For the purpose of this study, we selected a group of 118 patients embolised before 30/04/1997 (patient flow chart -1). Among them were 16 patients embolised abroad, lacking sufficient information are not included in this study. The population thus comprises 102 patients with 160 saccular aneurysms. Dissecting, traumatic, giant, fusiform, inflammatory and aneurysms associated with brain arteriovenous malformations are excluded (table 1) There were 71 female patients (69%) and 31 male patients (31%), aged 12-73 years (table  6) . Thirty-eight patients (37,2%) had multiple AAs with 17 mirror-type AAs (5 on the carotid-ophthalmic and PComA, 4 on MCA and 3 on cavernous ICA) (table 2). The loca-tion of the aneurysms is detailed in table 2 (76.5% on anterior and 23.5% on posterior circulation). Metameric distribution analysis 13 demonstrated 89 AA (76,5%) lying in the rostral region, 21 AA (18,5%) in the middle and 5 AA (5%) in the caudal region. One hundred G H Figure 1 Angiograms performed 6 years later (G,H) ilustrate later stability of results when AA kept unchanged for three consecutive years.
number of patients (table 5) . Among 116 treated AA, 98 (84.4%) were less than 10 mm in size, 15 (12.9%) measured between 10 and 15 mm and three (2.7%) measured between 16 and 25 mm. Eighty patients (78,5%) were treated in one procedure each, * a 63-year-old man embolised from an unruptured AcoA aneurysm presented a viral and alcoholic cirrhosis; listed to liver transplantation, he died 2 years later due to hepatic insuficiency. * a 45-year-old woman presenting SAH and 4 AA on angiogram, was Eo for 2 AA with immediate 100% and 90% occlusion rate, respectively. She died 10 days later while waiting for neurosurgery for a contralateral MCA AA. At autopsy, it was confirmed that previous embolized AA were intact but MCA aneurysm presented tear of its wall with attached haematoma. ** 1 a 56-year-old man Eo in 1994 from a basilar tip AA died in 09/1998 (4-yrs post Eo) from a massive pulmonary aspiration. 2 a 56-year-old woman with SAH, bled twice within 72 h (the later few minutes before Eo from a basilar tip-AA with a immediate 80% oclusion rate); the patient was Fisher = 4, WFNS = 3 and died 6 days later from a severe vasospasm and generalized infection. 3 a 51-year-old woman Eo from a basilar tip-AA, Fisher = 4, H&H = 2, Eo from a AcomA-AA with a immediate 90% occlusion rate, was neurologically normal 24 h after procedure following by progressive onset of systemic infection, with hypocoagulation state, hypothermia, and refratary arterial hypotension. CT and angiogram failed to demonstrate rebleeding. She died 1 week later from a septicemia. 4 a 41-year-old woman, Fisher = 4, H&H = 2 and severe vasospasm at angiography, Eo from basilar tip-AA and obtained a 80-89% of immediate occlusion rate; 2 days later presented headache with deterioration of her mental status, followed by coma at 4 th post operative day. CT showed no re bleed; presence of diffuse cerebral ischaemia compatible with vasospasm. 5 a 53-year-old woman, Fisher = 4, H&H = 3, WFNS = 3 and severe vasospasm on angiography, was Eo from a MCA-AA with a immediate 80% occlusion rate, with a neurological deterioration at 10 th day post SAH (Glascow Scale = 3/15). CT and angiogram were done: no rebleed was seen but severe ischaemia and vasospasm on MCA territory. She died 2 days later. 6 a 72-year-man, Fisher = 4, H&H = 3, Eo from AcoA-AA with neurologiacal deterioration at 6 th post operative; she was reintubed; CT showed no rebleed. Angiogram showed a diffuse vasospasm and subtotal (95%) occlusion of AA embolised. The patient died at 15 th day from a staphylococcemia and subsequent acute renal insufficiency. 7 a 52-year-old lady died 3 years post Eo due to thyroid carcinoma. + a 73-year-old woman Eo from a ruptured non surgical AcoA-AA, Fisher = 4,WFNS = 4, GS = 6/15, she initially presented cardiac arrest during her SAH; following embolisation she had a fibrinolysis for a throemboembolic event with secondary ICH. She died 1 week later with brain ischaemia secondary to severe vasospasm. *** No rebleeding from a embolised AA during follow-up among patients analysed and treated until 04/1997. However, 01 patient with a large AA treated after this interval of time presented aneurysm recanalisation being recommended re-intervention by endovascular reconstrutive technique after Balloon Test Occlusion or surgical by-pass but the patient refused it, rebled and died few months later. Failed embolisation in 9.4% was due to: access problems (tortuosity or anatomical situation in 4), atheroma (in one), or failure to deliver safely the coils (in 6) due to combined wide neck and tortuosity. All these last failures occurred in the anterior circulation, four of them (4/6) in patients with multiple AAs on supra-clinoid segment (1 carotid-ophthalmic, 1 superior hypophyseal, 2 bifurcations of ICA, one single carotid-ophthalmic AA and one AcomA). These failures occurred at the beginning of our experience pointing to inappropriate patient selection or non-availability of 3-D angiography and "remodelling technique" 14 .
One failed AcomA embolisation occured and it was due its perforation during delivery of the first coil. In this patient heparin was immediately stopped, the coil was delivered into aneurysmal sac and the patient referred for surgery. Although developing symptomatic spasm, he showed good recovery at follow-up.
Complications leading to permanent neurological deficits occurred in 3.8% of cases while transient neurological or non-neurological complications occurred in 12.7%. No mortality occurred in the unruptured aneurysms group. In the ruptured group, one non-surgical 71year-old female with a ruptured AcomA aneurysm (Fisher 4, WFNS 4 and GCS 6/15) died from haemorrhagic infarction after fibrinolysis for treatment of a thromboembolic event (table 8) .
Results
Treatment Follow-up
Initial angiograms. An immediate post embolisation angiogram was obtained for 105 treated aneurysms; 100% occlusion was achieved in 29 (27.6%), 90-99% in 55 (52.3%), 80-89% in 19 (18.1%) and less than 80% (poor) in 2 (2%).
Follow-up angiograms. 1-year follow-up angiography was performed in 85 patients with 98 embolised AA. Five initially completely occluded AA showed subtotal occlusion (90-99%). Conversely, 3 partially embolised (80-89%), plus 26 subtotally (99-90%) embolised aneurysms went on to total (100%) occlusion. Thus, spontaneous secondary thrombosis of incompletely embolised AAs occurred in 27.6% (29/105 AAs). Six patients died during the first year from the initial SAH itself. One among them harbored a second unruptured AA. Thus, overall 98 AAs have control angiogram at 1 year FU. 34 AAs (34,6%) showed morphological gain (29/34 achieved 100% occlusion), 42 AAs (42.8%) remained unchanged and 22 AAs (22.4%) showed deterioration (table 9). 22/98 aneurysms showed deterioration; 5/22 were initially complete occluded. Overall 3/22 remained subtotal AA (90-99%), 13/22 as partial (80-89%) and 6/22 as poorly embolised (< 80%). Five of these latter 6 aneurysms were re-embolised (one or more procedures) with one of them becoming completely occluded, 2 showing 90-99% occlusion and 2 with 80-89% occlusion all at 5-years FU. One patient harboring an Acom AA with less than 80% occlusion was not re-embolised due to the unfavorable shape of its neck (funnel shape); the patient refused surgery, his AA was excluded on the 3-y FU.
Clinical outcome at 1-year follow-up (FU) indicates that 88/102 patients (86.6%) have a good Karnovsky Score (i.e. KS 100-90, equiva-lent to GOS 1), 2.6% if one considers patients with unruptured AA only (table-10) .
Late angiographic follow-up. DSA long-term FU was available in 45 patients: at 5 years in 30, at 6 years in 5, at 7 years in 7, at 8 years in 2 and at 9 years in one patient. These 45 patients had 53 AAs of which 27 (51%) were ruptured and 26 (49%) unruptured (tables [11] [12] [13] . Of 24 AA with a immediate and also 1-year FU angiogram with a 100% occlusion rate, 14/24 patients were unchanged at 3-year FU but are lacking 5-year FU angiogram. Other 10/24 have a 1-y, 3-y and 5-year FU angiogram: 8 are unchanged and 2 have minimal recanalisation confirmed at 1-year control. 18 aneurysms initially showing subtotal occlusion (99-90%) and 2 AAs with partial occlusion (89-80%) showed spontaneous secondary thrombosis at 1-year angiography and remained unchanged 3-y and 5-years later. Overall, 28 total occlusion persisting after the first year post-embolisaton did not show any further changes at five years followup (figure 1). 25/28 AAs measured less than 10 mm, 2/28 between 10-15 mm and one between 16-25 mm. Twenty-three (82%) had necks < 4 mm and 5 had a neck > 4 mm (3 carotico-ophthalmic and 2 basilar tip). The sac/ neck diameter ratio was >2 in 19 AAs and between 1-2 in 9 AAs. Twelve AAs (43%) were ruptured and 16 unruptured (57%).
Among No bleeding or re-bleeding from a coiled, operated or conservatively managed AA was observed on long-term FU in this group.
One patient embolised for a ruptured Pco- aneurysms and a small MCA aneurysm (managed conservatively) were all intact, but the larger MCA aneurysm showed a tear and attached recent haematoma.
Our results show that patients with 100% occlusion at one year angiogram, had no late recanalisation at 5-year angio-FU. In the subtotal group, AA that were stable for three consecutive years showed no change on later angiogram. Thus, among aneurysms showing complete occlusion at the time of treatment, we found on serial angiograms, that this long-term stability was reached by one year.
Discussion
Guglielmi introduced endovascular coiling of saccular aneurysms in 1991 2,3 . Since then coiling of aneurysms has evolved rapidly during the past decade, now achieving a low rate of operative mortality as in our series with as 0% in unruptured AA group and 1,6% in ruptured AA group among 357 embolised AA since 1993. This compares favorably with the natural history of saccular AA and surgical series from similar groups of patients 18, 19 . Randomized studies favor embolisation over clipping of ruptured saccular AA of anterior circulation 5 , and there is a wide consensus for endovascular management of the posterior circulation AA 6, 7 .
Although its efficacy and safety in preventing early rebleeding have been proven in previous series 10,20-22 concern remains regarding three main issues: a) the long-term protection against rebleeding; b) the degree of angiographic obliteration of the aneurysmal sac necessary to achieve durable protection from re-haemorrhage; c) the duration of angiographic followup. Review of the pertinent literature shows that most series 20, 21, 23 failed to distinguish different types of aneurysms such as saccular, giant, flow-related, dissecting and fusiform. These are different diseases with different natural histories 24, 25 . Our group represents a significantly more homogeneous population including solely intradural saccular aneurysms.
Stability of Results
Cognard 22 found delayed thrombosis in 21% in a study of 203 aneurysms and Muyarama in 36% 26 . Hayakawa 27 noted that 50% of small embolised AA with small neck progressed to thrombosis against 25% in small AA with wide of aneurysmal rupture. On the angiogram four aneurysms were indentified; one P1-PCA and one carotid-ophthalmic (both embolised because of a bi-lobulated aspect, the caroticoophthalmic was thought to be responsible for the SAH) and two MCA aneurysms (mirror type). The patient bled 10 days after the 2 nd embolisation while awaiting surgery for the other MCA aneurysm. At autopsy, both embolised neck; however none of them provided long term results. If one considers this spontaneous thrombosis as an expected biological event, the risk in obtaining immediate morphological exclusion may outweigh the benefit, reason for which we did not recommend the use of the "remodelling technique" as well as "overpacking" in ruptured aneurysms at the acute stage. Several series [28] [29] [30] with mid-term angiographic and clinical FU have shown no rebleeding. Conversely, Byrne 21 reported rebleeding in 4 patients out of 317 (1.2%) treated, although angiographic FU was done at 6 months only; Viñuela 20 found a 2.2% rebleed rate but his series includes up to 39% of large and giant thrombosed aneurysms. After clipping, rebleeding is rare (reported to affect 0.5 to 3.7% of patients) with an estimated incidence of 0.79% per year [31] [32] [33] Timing of post clipping rebleed varies from as early as 1 month 25 to an average interval of 10.5 years 34 .
Porter 35 observed a "de novo" aneurysm formation rate of 0.76% of patients per year on high quality 3D-angio but prior studies have estimated rates of de novo formation up to 2% per year 36,37 on conventional DSA. We observed two newly-formed AAs among 102 patients. We have not encountered bleeding from a coiled aneurysm (in a 9-year experience from 1993, with 357 cases). Thus, one must always be cautious when referring to rebleeding from embolised or clipped AAs in fatal cases or non-angiographic proven cases because the haemorrhage may arises from a new grown aneurysm (figure 3).
Aneurysm Healing
Indeed, de novo AA there may be secondary to an intrinsically weak vessel (particularly on PCom and ACom arteries) probably because the underlying factors (pressure, flow direction, atheromatosis, shear stress, etc) continue their effects on an anatomical vulnerability 38, 39 . The routine use of high quality vascular images is essential in distinguishing multiple AAs from a single one. Autopsy data has confirmed angiographically "missed aneurysms", with 12% of patients thought to have a single, actually having more than one, and 8% of recognized multiple AAs on angiogram having more than expected 40 . The use of rotational angiography and 3-D reconstruction may even increase the amount of AA by showing not previously visi-ble lesion on posterior aspect of basilar tip, for example.
Viñuela 20 although finding a 2.2% rebleed rate overall, found no re-rupture of embolised AAs more than 3 years post treatment, whereas Byrne 21 stressed that all re-rupture in his series occurred before 36 months. Recently, Hyogo 41 reported 59 aneurysms assessed by angiography with no changes after 24 months of stability, but did not give details of subgroups. The vascular endothelium is believed to be completely remodeled and renewed every 3 years 42 and theoretically, one would expect that after injury and followed a reparation period, stability could be achieved, at least until the next cycle.
Definitive occlusion of an aneurysm requires growth of an intimal layer between the arterial lumen and the coil mesh. Ishihara 43 demonstrated that this intimal membrane can be identified as early as 2 weeks after embolisation of a small narrow neck AA. Conversely, Manabe 44 reported a later (8 month) re-rupture from an embolised AA in which no endothelial cell proliferation on the luminal surface (neck) was identified. Mawad 45 showed 6 month histopathological findings from embolised AAs in a canine study, with complete exclusion of mesh of coils from parent vessel by a layer of con- If the healing process in coil-embolised aneurysms involve a normal-cell to normal-cell interactions starting from of healthy edges of aneurysmal neck, justifying why smaller necks giving better occlusion rates remains an unclear phenomena but it probably involves biological rather than purely mechanical events. In this sense, Bouissou 46, 47 demonstrated that fibroblasts forming granulation tissue migrate from the edges of open wounds (like in wound healing by second intention). We have always used full heparinization in peri-operative and maintened for 24 hours after embolisation. The benefecial biological effects of heparin in promoting neck cicatrization in embolised AA has not been assessed yet but its role in wound healing has been demonstrated both in vitro and in vivo 48 . In cell culture studies, heparin and growth factors are associated with rapid and effective endothelial cell repair and many growth factors involved in wound healing bind to heparin being thereby stabilised and activated 49 . Furthermore, fibroblast growth factors are potent mitogens with angiogenic effects which play a critical role in wound healing; they require heparan sulfates as cofactors in order to activate their cognate receptors and exert their cellular and biological effects [50] [51] [52] [53] . Conversely, many centers do not use heparin routinely after coil-embolisation of AA and the consequent loss of its beneficial effects in the early hours after coil packing are not known. Finally, different centers do not use heparin after coiling but keep the patients under aspirin for several months post embolisation. Aspirin in animals studies delayed the healing process as shown in rats in which oral ulcers becomes completely healed on the10 th day in the control group compared with only 54% reduction in the ulcer area in the presence of aspirin 54 . The impact of these biological factors on our results can not be assessed at this point, but certainly, should be considered. Further investigations are clearly required at the biological level, to understand the healing process of coil-embolised aneurysms, and which will clarify the observations in our study.
Conclusions
Patient selection was not the purpose of this paper as it has been reported in previous publications 9, 10 . The aim was to evaluate the longterm stability obtained by coiling of saccular intradural AA (ruptured or unrupured) both morphologically and clinically.
We have observed the following: a) for AA where complete occlusion was achieved at immediate angiogram, long-term stability was obtained if stable at 1-year control angiogram; further angio control do not seen justified in this group. b) in AA with immediate subtotal occlusion where complete occlusion was achieved after secondary spontaneous thrombosis at 1-year angio-FU (27,6% in our series), long-term stability was always obtained and confirmed; further control angiogram do not seen justified in this group also. c) in AA that showed loss of morphology at 3-mo or 1-y had to be re embolized and followed up according to the date of the re-intervention; d) if immediate occlusion is < 80% re-intervention is required.
These observations and protocols in our series are valid in presence of multiple AA (37,2% in our series) 35 . In that series and during the follow-up period, no bleed / rebleed was observed.
Our observations were obtained from a population of patients whose saccular intradural AA were in the great majority less than 10 mm in size with a neck smaller than 4 mm. The topography of AA and Hunt and Hess grading for the ruptured ones, were similar to most surgical series; none of these AA were suggestive of giant, inflammatory, fusiform or dissecting ones, nor were flow-related. Our recommendations can not be extended to different population and profile.
